Author: Brian

Team science approach leverages expertise of researchers from diverse fields

Sonobiopsies generate genetic, molecular data to inform treatment decisions for brain diseases

Key steps leading to such accumulation identified; could inform new therapeutic approaches

Brain areas marked by distinct activity patterns very early, marsupial study shows

This episode of ‘Show Me the Science’ focuses on approval of a drug that attacks a key protein that contributes to dementia from Alzheimer’s disease

NIH-supported study lays groundwork for Alzheimer’s clinical trials involving people with intellectual disabilities

Provides baseline to measure progress toward racial equity in care for Alzheimer’s disease

Novel marker found in cerebrospinal fluid also could speed development of Alzheimer’s drugs

Proof-of-concept device could also monitor for flu, RSV, other respiratory viruses

This episode of ‘Show Me the Science’ focuses on research into how psychedelic drugs affect the brain and how such effects might help treat anxiety, depression and addiction

Accurate diagnosis is a crucial step toward appropriate treatment

Gut microbes of people with pre-symptomatic Alzheimer’s differ from those of healthy people

As children age, such brain activity becomes similar to how the brains of peers process such cues

Scientists, engineers receive small-business development grant

Award will help advance neuroscience technologies aimed at improving cognitive wellness